Pharmafile Logo
Pharmafocus logo
Advanced Search

cannabis

Showing 15 posts of 28 posts found.

GW Pharma’s cannabidiol gains EC approval

April 21, 2021
Research and Development EC, EU, cannabis

GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …

News
cbdx

NHS guidelines on prescription cannabis to be challenged in court

August 18, 2020
Manufacturing and Production, Research and Development CBD, cannabis, epilepsy

The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …

News
home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020
Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …

News
cbd-ol-cbd-oil-hemp-oil-oil-cbd-superfood

NHS to fast track cannabis-based treatment for epilepsy

December 23, 2019
Sales and Marketing CBD, CBD Oil, cannabis, drug treatment, epilepsy, thc

The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in …

News
45556314805_5531f47ed8_b

British Pharmacists call for regulation on non-medicinal CBD products

December 17, 2019
Manufacturing and Production CBD, CBD Oil, CBD Products, cannabis

Pharmacists are calling for more checks on products containing Cannabis derivative cannabidiol (CBD) that are sold in shops across the …

News
insider_interview_andrew_roach

A new weapon against Parkinson’s-related psychosis

December 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, cannabidiol, cannabis, feature, pharma

Dr Arthur Roach, Director of Research at the charity Parkinson’s UK, discusses new trials on cannabidiol in the treatment of …

Feature
https__cdn

NICE refuses GW Pharma’s cannabis-based Epidyolex for treatment-resistant epilepsy

August 27, 2019
Manufacturing and Production, Sales and Marketing Epidiolex, Epidyolex, GW Pharma, NICE, cannabidiol, cannabis, pharma

UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …

News
cannabis-2152604_960_720

Hundreds of patients turn to private cannabis clinics in UK

August 16, 2019
Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …

News
medicinal_cannabis_uk_review

Medicinal cannabis company Spectrum makes first shipment into UK

August 7, 2019
Research and Development Spectrum, UK, cannabis, medicinalcannabis, pharma

Medicinal cannabis company Spectrum Europe has made its first shipment of cannabis into the UK, making it one of the …

News
https__cdn

GW Pharma’s cannabis-based Epidyolex edges closer to EU approval with positive CHMP opinion in epilepsy

July 26, 2019
Medical Communications, Sales and Marketing EMA, Epidiolex, Europe, GW Pharma, cannabis, epilepsy

UK-based biotech GW Pharmaceuticals has announced that its cannabidiol oral solution Epidyolex has secured recommendation from the European Medicines Agency’s …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma

The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …

News
gwpharma

GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial

May 7, 2019
Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc

GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …

News
about2medical

Medical cannabis: A green light for patients in need?

April 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …

Feature
cannabis-2152604_960_720

Africa’s legal cannabis market could generate $7.1 billion each year by 2023

March 25, 2019
Sales and Marketing Africa, UN, cannabis, medicnial cannabis, prohibition partners

Africa’s legal cannabis market could generate more than $7.1 billion each year by 2023, according to a report from market …

News
medicinal_cannabis_uk_review

Scientists genetically modify yeast to produce CBD and THC

February 28, 2019
Research and Development Medical marijuana, berkely, cannabis, science, yeast

Researchers at the University of California, Berkeley have genetically modified brewer’s yeast so that it produces two common cannabinoids: tetrahydrocannabinol …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023